Amazon hires a new cardiologist to its healthcare division

By Catherine Sturman
Social media has taken the world by storm. Senior leadership figures, such as Elon Musk and even President Trump regularly post updates through platform...

Social media has taken the world by storm. Senior leadership figures, such as Elon Musk and even President Trump regularly post updates through platforms such as Twitter, and now another popular healthcare figure through this digital tool.

Well-known, admired cardiologist Maulik Majmudar has revealed he is set to join Amazon in an undisclosed role, with the aim to “make a truly meaningful impact on the health and wellbeing of hundreds of millions of individuals throughout the world,” he said through Twitter.

Within previous roles as Cardiologist and Associate Director at Massachusetts General Hospital, as well as lecturing and exceptional training at the esteemed Harvard Medical School, Northwestern Memorial Hospital, amongst others, Majmudar is passionate about embracing new technologies which will help transform the industry for the future.

See also

With this in mind, Majmudar has also worked as a medical adviser at Biofourmis, which has been described as “the world’s most sophisticated HIPAA compliant personalised health analytics platform based on human physiology which uses digital mHealth devices and bio-sensors to capture important clinical information towards building a precise predictive analytics engine.”

Navigating through the ongoing complexities within healthcare, from complex regulations to data protection, Amazon has hired a number of high profile figures to its health team, such as Taha Kass-Hout, former FDA Chief Health Information Officer and healthcare leader Dr Atul Gawande.

Exploring areas such as pharmacy wholesale distribution, acquiring companies such as PillPack and Xealth, the development of new medical devices and use of AI to compete against rivals such as Walgreens, as well as launch its own healthcare clinics for employees.

It’s partnership with Berkshire Hathaway and JP Morgan Chase will also further its goal to reduce ongoing escalating healthcare costs across the US, with Dr Gawande leading this venture.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare